Hallucinogen related disorders
Chapter 5:Mental, Behavioral and Neurodevelopmental disorders
ICD-10 F16 is a billable code used to indicate a diagnosis of hallucinogen related disorders.
Hallucinogen related disorders encompass a range of conditions associated with the use of hallucinogenic substances, which can lead to significant alterations in perception, mood, and cognitive processes. These disorders include hallucinogen use disorder, hallucinogen intoxication, and hallucinogen withdrawal. Individuals may experience visual or auditory hallucinations, altered sense of time, and profound changes in thought processes. The use of hallucinogens can lead to psychological dependence, although physical dependence is less common. Treatment often involves behavioral therapies, counseling, and support groups, as well as addressing any co-occurring mental health disorders. Accurate diagnosis requires a thorough clinical assessment, including a detailed history of substance use and its impact on daily functioning. Clinicians must differentiate between hallucinogen-related disorders and other mental health conditions, such as schizophrenia or mood disorders, to ensure appropriate treatment and coding.
Detailed patient history, including substance use patterns and mental health evaluations.
Patients presenting with acute psychosis or mood disturbances following hallucinogen use.
Consideration of differential diagnoses such as schizophrenia or bipolar disorder.
Comprehensive assessment of substance use, including frequency, duration, and impact on functioning.
Patients seeking treatment for hallucinogen dependence or experiencing withdrawal symptoms.
Integration of behavioral therapies and support systems in treatment planning.
Used for follow-up visits for patients with hallucinogen use disorder.
Document the patient's history, current symptoms, and treatment plan.
Psychiatric evaluations may require additional documentation of mental status and risk assessments.
Hallucinogen intoxication refers to the acute effects experienced after using hallucinogens, including altered perceptions and mood changes. In contrast, hallucinogen use disorder is characterized by a pattern of problematic use leading to significant impairment or distress, including cravings and withdrawal symptoms.
